Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.

Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O'Donnell DE, Maltais F, Mularski RA, Cave AJ, Mayers I, Kennedy V, Oliver TK, Brown C; Canadian Thoracic Society COPD Committee Dyspnea Expert Working Group.

Can Respir J. 2011 Mar-Apr;18(2):69-78. Review.

2.

Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Bausewein C, Booth S, Gysels M, Higginson I.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005623. doi: 10.1002/14651858.CD005623.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD005623.

PMID:
18425927
3.

Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.

Rocker G, Horton R, Currow D, Goodridge D, Young J, Booth S.

Thorax. 2009 Oct;64(10):910-5. doi: 10.1136/thx.2009.116699. Review.

PMID:
19786716
4.

Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.

Janssen DJ, de Hosson SM, bij de Vaate E, Mooren KJ, Baas AA.

Chron Respir Dis. 2015 May;12(2):85-92. doi: 10.1177/1479972315571926. Epub 2015 Feb 12.

PMID:
25676931
5.

Contemporary issues in refractory dyspnoea in advanced chronic obstructive pulmonary disease.

Horton R, Rocker G.

Curr Opin Support Palliat Care. 2010 Jun;4(2):56-62. doi: 10.1097/SPC.0b013e328338c1c6. Review.

PMID:
20407378
6.

Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists.

Young J, Donahue M, Farquhar M, Simpson C, Rocker G.

Can Fam Physician. 2012 Jul;58(7):e401-7.

7.

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.

Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society.

Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.

PMID:
21810710
8.

A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.

Verberkt CA, van den Beuken-van Everdingen MH, Franssen FM, Dirksen CD, Schols JM, Wouters EF, Janssen DJ.

Contemp Clin Trials. 2016 Mar;47:228-34. doi: 10.1016/j.cct.2016.01.007. Epub 2016 Jan 26.

PMID:
26825021
9.

Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD.

Norweg A, Collins EG.

Int J Chron Obstruct Pulmon Dis. 2013;8:439-51. doi: 10.2147/COPD.S30145. Epub 2013 Sep 25. Review.

10.

The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?

Horton R, Rocker G, Currow D.

Curr Opin Support Palliat Care. 2010 Jun;4(2):92-6. Review.

PMID:
20443250
11.

Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches.

Ora J, Jensen D, O'Donnell DE.

Curr Opin Pulm Med. 2010 Mar;16(2):144-9. doi: 10.1097/MCP.0b013e328334a728. Review.

PMID:
19926997
12.

Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.

Varkey B.

Curr Opin Pulm Med. 2010 Mar;16(2):150-4. doi: 10.1097/MCP.0b013e3283364378. Review.

PMID:
20071992
13.

Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.

Rocker G, Young J, Donahue M, Farquhar M, Simpson C.

CMAJ. 2012 Jun 12;184(9):E497-504. doi: 10.1503/cmaj.111758. Epub 2012 Apr 23.

14.

Approach to chronic obstructive pulmonary disease in primary care.

Todd DC, McIvor RA, Pugsley SO, Cox G.

Can Fam Physician. 2008 May;54(5):706-11. Review.

15.

Randomized controlled trial of mindfulness-based therapy for dyspnea in chronic obstructive lung disease.

Mularski RA, Munjas BA, Lorenz KA, Sun S, Robertson SJ, Schmelzer W, Kim AC, Shekelle PG.

J Altern Complement Med. 2009 Oct;15(10):1083-90. doi: 10.1089/acm.2009.0037.

PMID:
19848546
16.

Management of dyspnea in patients with chronic obstructive pulmonary disease.

Abernethy AP, Uronis HE, Wheeler JL, Currow DC.

Wien Med Wochenschr. 2009 Dec;159(23-24):583-90. doi: 10.1007/s10354-009-0727-z. Review.

PMID:
20151347
17.

Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.

Smallwood N, Le B, Currow D, Irving L, Philip J.

Intern Med J. 2015 Sep;45(9):898-904. doi: 10.1111/imj.12857.

PMID:
26332621
18.

Pharmacological management of dyspnoea.

Currow DC, Abernethy AP.

Curr Opin Support Palliat Care. 2007 Aug;1(2):96-101. doi: 10.1097/SPC.0b013e3282ef5e03. Review.

PMID:
18685349
19.

Palliative management of refractory dyspnea in COPD.

Uronis HE, Currow DC, Abernethy AP.

Int J Chron Obstruct Pulmon Dis. 2006;1(3):289-304. Review.

20.

Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.

Ekström M, Nilsson F, Abernethy AA, Currow DC.

Ann Am Thorac Soc. 2015 Jul;12(7):1079-92. doi: 10.1513/AnnalsATS.201501-034OC. Review.

PMID:
25803110

Supplemental Content

Support Center